Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins

Molecular and Cellular Biology

Volumn 17, Issue 2, 1997, Pages 584-593

  Lenormand, Jean Luc ^a,c   Benayoun, Béatrice ^a   Guillier, Martine ^a   Vandromme, Marie ^b   Leibovitch, Marie Pierre ^a   Leibovitch, Serge A ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Centre National de la Recherche Scientifique   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; GLUTATHIONE TRANSFERASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL LYSATE; DIMERIZATION; DNA BINDING; GENE EXPRESSION; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; RAT; REPORTER GENE; REPRESSOR GENE;

EID: 0031038586     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.2.584     Document Type: Article

References (66)

1. Bai, W., B. Singh, Y. Yang, L. Ramagli, M. Nash, N. K. Herzog, and R. B. Arlinghaus. 1992. The physical interactions between p37 env-mos and tubulin structures. Oncogene 7:493-500.
2. cdc2 isoform. Oncogene 7:1757-1763.
3. Benezra, R., R. L. Davis, D. Lockshon, D. L. Turner, and H. Weintraub. 1990. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61:49-59.
4. Borycki, A. G., M. Guillier, M. P. Leibovitch, and S. A. Leibovitch. 1992. Molecular cloning of CSF-1 receptor from rat myoblasts. Sequence analysis and regulation during myogenesis. Growth Factors 6:209-218.
5. Boyle, W. J., T. Smeal, L. H. L. Defize, P. Angel, J. R. Woodgett, M. Karim, and T. Hunter. 1991. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity Cell 64:573-584.
6. Braun, T., G. Buschhausen-Denker, E. Bober, E. Tannich, and H. H. Arnold. 1989. A novel human muscle factor related to hut distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J. 8:701-709.
7. Brennan, T. J., T. Chakraborty, and E. N. Olson. 1991. Mutagenesis of the myogenin basic region identifies an ancient protein motif critical for activation of myogenesis. Proc. Natl. Acad. Sci. USA 88:5675-5679.
8. Buskin, J. N., and S. D. Hauschka. 1989. Identification of a myocyte nuclear factor which binds to the muscle-specific enhancer of the mouse muscle creatine kinase gene. Mol. Cell. Biol. 9:2627-2640.
9. Chakraborty, T., and E. N. Olson. 1991. Domains outside of the DNA-binding domain impart target gene specificity to myogenin and MRF4. Mol. Cell. Biol. 11:6103-6108.
10. Colledge, W. H., M. B. L. Carlton, G. B. Udy, and M. J. Evans. 1994. Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs. Nature 370:65-68.
11. Davis, R. L., H. Weintraub, and A. B. Lassar. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987-1000.
12. Davis, R. L., P. Cheng, A. B. Lassar, and H. Weintraub. 1990. The MyoD DNA binding domain contains a recognition code for muscle specific gene activation. Cell 60:733-746.
13. Edmondson, D. G., and E. N. Olson. 1989. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev. 3:628-640.
14. Falcone, G., F. Tato, and S. Alema. 1985. Distinctive effects of the viral oncogene myc, erb, fps, and src on the differentiation program of quail myogenic cells. Proc. Natl. Acad. Sci. USA 82:426-430.
15. Xe. Mol. Cell. Biol. 11:1713-1717.
16. Goldman, D. S., A. A. Kiessling, C. F. Millette, and G. M. Cooper. 1987. Expression of c-mos RNA in germ cells of male and female mice. Proc. Natl. Acad. Sci. USA 84:4509-1513.
17. Groisman, R., H. Masutani, M. P. Leibovitch, P. Robin, I. Soudéan, D. Trouche, and A. Harel-Bellan. 1996. Physical interaction between the mitogen-responsive serum response factor and myogenic basic-helix-loop-helix. J. Biol. Chem. 271:5258-5264.
18. Hashimoto, N., N. Watanabe, Y. Furuta, H. Tamemoto, N. Sagata, M. Yokoyama, K. Okazaki, M. Nagayoshi, N. Takeda, and Y. Ikawa. 1994. Parthenogenetic activation of oocytes in c-mos-deficient mice. Nature 370: 68-71.
19. Herzog, N. K., L. S. Ramagli, S. Khorana, and R. B. Arlinghaus. 1989. Somatic cell expression of the c-mos protein. Oncogene 4:1307-1315.
20. Hu, J. S., E. N. Olson, and R. E. Kingston. 1992. HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors. Mol. Cell. Biol. 12:1031-1042.
21. Kaelin, W. G., D. C. Pallas, J. A. DeCaprio, F. Kaye, and D. M. Livingston. 1991. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell 64:521-532.
22. Kuruta, N., H. Akiyama, T. Taniyama, and T. Marunouchy. 1989. Dose-dependent regulation of macrophage differentiation by v-mos mRNA in a human monocytic cell line. EMBO J. 8:457-463.
23. Kuruta, N., H. Akiyama, H. Hosoya, H. Aoki, K. Ishikawa, and T. Marunouchi. 1995. Mutations in the v-mos gene abolish its ability to induce differenciation but not transformation. Eur. J. Cell Biol. 68:55-61.
24. Lassar, A. B., J. N. Buskin, D. Lockshon, R. L. Davis, S. N. Apone, S. D. Hauschka, and H. Weintraub. 1989. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell 58:823-831.
25. Lassar, A. B., M. J. Thayer, R. W. Overell, and H. Weintraub. 1989. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1 Cell 58:659-667.
26. Leibovitch, M. P., S. A. Leibovitch, J. Hillion, A. Schmitz, and J. Harel. 1987. Possible roles of c-fos, c-ras and c-mos proto-oncogenes in muscular development. Exp. Cell. Res. 170:80-92.
27. Leibovitch, M. P., B. Solhonne, M. Guillier, P. Verelle, and S. A. Leibovitch. 1995. Direct relationship between the expression of tumor suppressor H19 mRNA and c-mos proto-oncogene during myogenesis. Oncogene 10:251-260.
28. Leibovitch, S. A., J. L. Lenormand, M. P. Leibovitch, M. Guillier, L. Mallard, and J. Harel. 1990. Rat myogenic c-mos: cloning, sequence analysts and regulation during muscle development. Oncogene 5:1149-1157.
29. Leibovitch, S. A., M. Guillier, J. L. Lenormand, and M. P. Leibovitch. 1991. Accumulation of the c-mos protein is correlated with post-natal development of skeletal muscle. Oncogene 6:1617-1622.
30. Leibovitch, S. A., M. Guillier, J. L. Lenormand, and M. P. Leibovitch. 1993. p34cdc2 protein is complexed with the c-mos protein in rat skeletal. Oncogene 8:2361-2369.
31. Lenormand, J. L. Unpublished data.
32. Lenormand, J. L., M. Guillier, and S. A. Leibovitch. 1993. Identification of a cis acting element responsible for muscle specific expression of the c-mos proto-oncogene. Nucleic Acids Res. 21:695-702.
33. Li, C. C. H., E. Chen, D. O'Connell, and D. L. Longo. 1993. Detection of c-mos proto-oncogene expression in human cells. Oncogene 8:1685-1691.
34. Li, L., J. C. Chambard, M. Karin, and E. N. Olson. 1992. Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression. Genes Dev. 6:676-689.
35. Li, L., R. Heller-Harrison, M. Czech, and E. N. Olson. 1992. Cyclic AMP-dependent protein kinase inhibits the activity of myogenic helix-loop-helix proteins. Mol. Cell. Biol. 12:4478-4485.
36. Li, L., J. Zhou, G. James, R. Heller-Harrison, M. P. Czech, and E. N. Olson. 1992. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell 71:1181-1194.
37. Miner, J. H., and B. Wold. 1990. Herculin, a fourth member of the MyoD family of mygenic regulatory genes. Proc. Natl. Acad. Sci. USA 87:1089-1093.
38. Miner, J. H., and B. Wold. 1991. c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation. Mol. Cell. Biol. 11:2842-2851.
39. Mitsui, K., M. Shirakata, and B. M. Paterson. 1993. Phosphorylation inhibits the DNA-binding activity of MyoD homodimers but not MyoD-E12 heterodimers. J. Biol. Chem. 268:24415-24420.
40. Mueller, P. R., and B. Wold. 1989. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science 246:780-786.
41. Murre, C., P. S. McCaw, and D. Baltimore. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD and myc proteins. Cell 56:777-783.
42. Murre, C., P. S. McCaw, H. Vaessin, M. Caudy, L. Y. Jan, Y. N. Jan, C. V. Cabrera, J. N. Buskin, S. D. Hauschka, and A. B. Lassar. 1989. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58:537-544.
43. Nebreda, A. R., and T. Hunt. 1993. The c-mos proto-oncogene protein kinase turns on and maintains the activity of MAP kinase, but not MPF, in cell-free extracts of Xenopus oocytes and eggs. EMBO J. 12:1979-1986.
44. Okazaki, K., M. Nishizawa, N. Furuno, H. Yasuda, and N. Sagata. 1992. Differential occurrence of CSF-like activity and transforming activity of Mos during the cell cycle in fibroblasts. EMBO J. 11:2447-2456.
45. Olson, E. N., G. Spizz, and M. Tainsky. 1987. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol. Cell. Biol. 7:2801-2806.
46. Olson, E. N. 1990. MyoD family: a paradigm for development? Genes Dev. 4:1454-1461.
47. Olson, E. N. 1993. Interplay between proliferation and differentiation within the myogenic lineage. Genes Dev. 4:1454-1461.
48. Posada, J., N. Yew, N. Ahn, G. F. Vande Woude, and J. A. Cooper. 1993. Mos stimulates mitogen-activated protein (MAP) kinase m Xenopus oocytes and activates a MAP kinase kinase in vitro. Mol. Cell. Biol. 13:2546-2553.
49. Shibuya, E. K., and V. V. Ruderman. 1993. Mos induces the in vitro activation of mitogen-activated protein kinases in lysates of frog oocytes and mammalian somatic cells. Mol. Biol. Cell 4:781-790.
50. Propst, F., and G. F. Vande Woude. 1985. C-mos proto-oncogene transcripts are expressed in mouse tissues. Nature 315:516-518.
51. Rhodes, S. J., and S. F. Konieczny. 1989. Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev. 3:2050-2061.
52. Rudnicki, M. A., P. N. J. Schnegelsberg, R. H. Stead, T. Braun, H. H. Arnold, and R. Jaenisch. 1993. MyoD or Myf5 is required for the formation of skeletal muscle. Cell 75:1351-1359.
53. Sagata, N., M. Oskarsson, T. Copeland, J. Brumbaugh, and G. F. Vande Woude. 1988. Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes. Nature 335:519-525.
54. Schlissel, M., A. Voronova, and D. Baltimore. 1991. Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. Genes Dev. 5:1367-1376.
55. Schmidt, M., M. K. Oskarsson, J. K. Dunn, D. G. Blair, S. Hughes, F. Propst, and G. F. Vande Woude. 1985. Chicken homolog of the mos protooncogene. Mol. Cell. Biol. 8:923-929.
56. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusion of glutathione-S-transferase. Gene 67:31-40.
57. Tapscott, S. J., R. L. Davis, M. J. Thayer, P. Cheng, H. Weintraub, and A. B. Lassar. 1988. MyoD1: a nuclear phosphoprotein requiring a myc homology region to convert fibroblasts to myoblasts. Science 242:405-411.
58. Vandromme, M., G. Carnac, C. Gauthier-Rivière, D. Fesquet, N. Lamb, and A. Fernandez. 1994. Nuclear import of the myogenic factor MyoD requires cAMP-dependent protein kinase activity but not the direct phosphorylation of MyoD. J. Cell Sci. 107:613-620.
59. Wayne, T. M., and G. F. Vande Woude. 1994. Cell cycle control and early embryogenesis: Xenopus laevis maturation and early embryonic cell cycles. Dev. Biol. 5:173-181.
60. Webster, K. A., G. E. O. Muscat, and L. Kedes. 1988. Adenovirus E1A product suppress myogenic differentiation and inhibit transcription from muscle-specific promoters. Nature 332:553-557.
61. Weintraub, H., R. Davis, D. Lockshon, and A. B. Lassar. 1990. MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation. Proc. Natl. Acad. Sci. USA 87:5623-5627.
62. Weintraub, H. 1993. The MyoD Family and myogenesis: redundancy networks and thresholds. Cell 75:1241-1244.
63. Winter, B., T. Braun, and H. H. Arnold. 1993. cAMP-dependent protein kinase represses myogenic differentiation and the activity of the muscle-specific helix-loop-helix transcription factors Myf5 and MyoD. J. Biol. Chem. 268:9869-9878.
64. Wright, W. E., D. A. Sassoon, and V. K. Lin. 1989. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56:607-617.
65. Yew, N., M. Oskarsson, I. Daar, D. G. Blair, and G. F. Vande Woude. 1991. mos transforming efficiencies correlate with oocyte maturation and cytostatic factor activities. Mol. Cell. Biol. 11:604-610.
66. Zhou, R., M. Oskarsson, R. S. Paules, N. Schulz, D. Cleveland, and G. F. Vande Woude. 1991. Ability of the c-mos product to associate with and phosphorylate tubulin. Science 251:671-675.